Evidence map›Paper›PMID 21874388›Full record

ArticleMolecular imaging and biology2012

A multimode optical imaging system for preclinical applications in vivo: technology development, multiscale imaging, and chemotherapy assessment.

Jae Youn Hwang, Sebastian Wachsmann-Hogiu, V Krishnan Ramanujan, Julia Ljubimova, Zeev Gross, Harry B Gray, Lali K Medina-Kauwe, Daniel L Farkas

Open access · greenAbstract read
In one paragraph

Article in Molecular imaging and biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. The role of corroles in modern cancer therapy: innovation and prospects.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review of quantitative multiscale imaging of breast cancer.Journal of medical imaging (Bellingham, Wash.) · 2018
    Review
  8. Article
  9. Article
  10. Fighting Cancer with Corroles.Chemical reviews · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Jae Youn HwangMinimally Invasive Surgical Technologies Institute and Department of Surgery, Cedars-Sinai Medical Center, 8700 Beverly Blvd. D6061, Los Angeles, CA 90048, USA. hwangjy@cshs.org
Sebastian Wachsmann-Hogiu
V Krishnan Ramanujan
Julia Ljubimova
Zeev Gross
Harry B Gray
Lali K Medina-Kauwe
Daniel L Farkas
Cedars-Sinai Medical Center · USCalifornia Institute of Technology · USTechnion – Israel Institute of Technology · ILUniversity of California, Davis · USUniversity of California, Los Angeles · US

Funding

Tumor Targeted Corroles for Detection and InterventionR01CA140995 · NCI · CEDARS-SINAI MEDICAL CENTER · PI MEDINA-KAUWE, LALI K · 2010 to 2021
$3.7M
Protein-DNA Drug Carriers for Tumor TargetingR01CA129822 · NCI · CEDARS-SINAI MEDICAL CENTER · PI MEDINA-KAUWE, LALI K · 2009 to 2020
$3.0M
Nanoconjugate based on polymalic acid for brain tumor treatmentU01CA151815 · NCI · CEDARS-SINAI MEDICAL CENTER · PI LJUBIMOVA, JULIA Y · 2010 to 2014
$2.7M
Tumor drug delivery systems based on polymalic acidR01CA123495 · NCI · CEDARS-SINAI MEDICAL CENTER · PI LJUBIMOVA, JULIA Y · 2006 to 2010
$1.4M
NON-INVASIVE OPTICAL IMAGING IN VIVO FOR EARLY DETECTIONN01CO007119 · CO · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FARKAS, DANIEL L · 2000 to 2000
$500k
NCI NIH HHS 1R01 CA129822)NCI NIH HHS 1R01 CA140995NCI NIH HHS 1U01CA151815-0NCI NIH HHS 5R01CA123495-03NCI NIH HHS N01-CO 07119NCI NIH HHS R01 CA123495NCI NIH HHS R01 CA129822NCI NIH HHS R01 CA140995NCI NIH HHS U01 CA151815
6 · The paper itself

Abstract

purposeSeveral established optical imaging approaches have been applied, usually in isolation, to preclinical studies; however, truly useful in vivo imaging may require a simultaneous combination of imaging modalities to examine dynamic characteristics of cells and tissues. We developed a new multimode optical imaging system designed to be application-versatile, yielding high sensitivity, and specificity molecular imaging. PROCEDURES: We integrated several optical imaging technologies, including fluorescence intensity, spectral, lifetime, intravital confocal, two-photon excitation, and bioluminescence, into a single system that enables functional multiscale imaging in animal models.

resultsThe approach offers a comprehensive imaging platform for kinetic, quantitative, and environmental analysis of highly relevant information, with micro-to-macroscopic resolution. Applied to small animals in vivo, this provides superior monitoring of processes of interest, represented here by chemo-/nanoconstruct therapy assessment.

conclusionsThis new system is versatile and can be optimized for various applications, of which cancer detection and targeted treatment are emphasized here.

Indexed as

Optical DevicesXenograft Model Antitumor AssaysAnimalsAntineoplastic AgentsCell Line, TumorFeasibility StudiesHumansLuminescent MeasurementsMiceMice, NudeMolecular ImagingNanoparticlesNeoplasmsOrgan SpecificityRatsSpectrometry, FluorescenceAntineoplastic Agents

Identifiers

PMID21874388
PMCPMC3487699
OpenAlexW1978989480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.